We are live on ! Find out more
II

Ibex Investors Portfolio holdings

AUM $152M
1-Year Est. Return 19.17%
This Fund
S&P 500
This Quarter Est. Return
-18.71%
1 Year Est. Return
-19.17%
3 Year Est. Return
-4.48%
5 Year Est. Return
-29.66%
10 Year Est. Return
AUM
$614M
AUM Growth
+$434M
Cap. Flow
+$406M
Cap. Flow %
66.04%
Top 10 Hldgs %
84.85%
Holding
290
New
87
Increased
37
Reduced
23
Closed
135

Sector Composition

Rank Sector Weight
1 Technology 13.56%
2 Healthcare 3.35%
3 Consumer Discretionary 2.12%
4 Energy 1.69%
5 Industrials 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
51
Alaunos Therapeutics
TCRT
$4.65M
$755K 0.12%
+2,691
New +$1.06M
CORE
52
DELISTED
Core Mark Holding Co., Inc.
CORE
$751K 0.12%
32,327
-7,149
-18% -$218K
PES
53
DELISTED
Pioneer Energy Services Corp.
PES
$690K 0.11%
561,236
+176,873
+46% +$440K
BW icon
54
Babcock & Wilcox
BW
$1.42B
$425K 0.07%
108,952
-21,256
-16% -$189K
VTGN icon
55
VistaGen Therapeutics
VTGN
$10.1M
$270K 0.04%
6,000
MGNI icon
56
Magnite
MGNI
$2.8B
$250K 0.04%
+66,891
New +$255K
AYX
57
DELISTED
Alteryx Inc
AYX
$250K 0.04%
4,200
+682
+19% +$37K
TWLO icon
58
Twilio
TWLO
$29.8B
$247K 0.04%
2,755
+241
+10% +$19.6K
GLUU
59
DELISTED
Glu Mobile Inc.
GLUU
$239K 0.04%
29,601
+1,112
+4% +$7.91K
CALX icon
60
Calix
CALX
$2.35B
$238K 0.04%
+24,428
New +$213K
RETA
61
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$238K 0.04%
+4,239
New +$259K
ABMD
62
DELISTED
Abiomed Inc
ABMD
$238K 0.04%
+733
New +$255K
BEAT
63
DELISTED
BioTelemetry, Inc.
BEAT
$237K 0.04%
3,959
+574
+17% +$34.5K
GDOT icon
64
Green Dot
GDOT
$754M
$235K 0.04%
+2,948
New +$233K
WTI icon
65
W&T Offshore
WTI
$522M
$235K 0.04%
+56,959
New +$364K
EVH icon
66
Evolent Health
EVH
$353M
$234K 0.04%
+11,742
New +$272K
AMED
67
DELISTED
Amedisys
AMED
$232K 0.04%
1,976
+254
+15% +$29.9K
EXAS
68
DELISTED
Exact Sciences
EXAS
$232K 0.04%
+3,679
New +$252K
KTOS icon
69
Kratos Defense & Security Solutions
KTOS
$9.23B
$232K 0.04%
+16,456
New +$227K
ETSY icon
70
Etsy
ETSY
$7.89B
$231K 0.04%
+4,843
New +$228K
FATE icon
71
Fate Therapeutics
FATE
$291M
$231K 0.04%
+18,000
New +$251K
NEO icon
72
NeoGenomics
NEO
$2.04B
$231K 0.04%
+18,260
New +$272K
WK icon
73
Workiva
WK
$3.43B
$231K 0.04%
6,435
+823
+15% +$28.9K
CHGG icon
74
Chegg
CHGG
$114M
$230K 0.04%
+8,071
New +$217K
DXCM icon
75
DexCom
DXCM
$32.9B
$230K 0.04%
7,668
+1,772
+30% +$56.2K

Similar funds

Ibex Investors's Q4 2018 Portfolio in Review

As of Q4 2018, Ibex Investors held 290 positions worth $614M, up 241% from $180M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Ibex Investors deployed $406M of net new capital in Q4 2018, opening 87 new positions and adding to 37 existing holdings. Its largest new stake was Tower Semiconductor: 747,000 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 44% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Ceragon Networks, an estimated $2.08M trimmed.

  • Ibex Investors's largest Q4 2018 buy was Tower Semiconductor: 747,000 shares worth $11M.
  • Ibex Investors added most to Noble Energy, Inc. in Q4 2018, an estimated $7.16M increase.
  • Ibex Investors's biggest Q4 2018 reduction was Ceragon Networks, cutting an estimated $2.08M.
  • Ibex Investors fully exited Perrigo in Q4 2018, selling an estimated $8.85M.
  • Ibex Investors's ten largest holdings make up 85% of its $614M portfolio in Q4 2018.
  • Ibex Investors opened 87 new positions and closed 135 in Q4 2018.
  • Ibex Investors's portfolio value rose 241% quarter-over-quarter to $614M.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.